“ID3021 Acquired resistance to with EGFR tyrosine kinase inhibitors by the EGFR T790M mutation in non-small cell lung cancer”, Biomed. Res. Ther., vol. 4, no. S, p. S33, Sep. 2017, doi: 10.15419/bmrat.v4iS.243.